Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice
- PMID: 22863420
- PMCID: PMC4310462
- DOI: 10.1016/j.chom.2012.07.004
Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice
Abstract
Colitis results from breakdown of homeostasis between intestinal microbiota and the mucosal immune system, with both environmental and genetic influencing factors. Flagellin receptor TLR5-deficient mice (T5KO) display elevated intestinal proinflammatory gene expression and colitis with incomplete penetrance, providing a genetically sensitized system to study the contribution of microbiota to driving colitis. Both colitic and noncolitic T5KO exhibited transiently unstable microbiotas, with lasting differences in colitic T5KO, while their noncolitic siblings stabilized their microbiotas to resemble wild-type mice. Transient high levels of proteobacteria, especially enterobacteria species including E. coli, observed in close proximity to the gut epithelium were a striking feature of colitic microbiota. A Crohn's disease-associated E. coli strain induced chronic colitis in T5KO, which persisted well after the exogenously introduced bacterial species had been eliminated. Thus, an innate immune deficiency can result in unstable gut microbiota associated with low-grade inflammation, and harboring proteobacteria can drive and/or instigate chronic colitis.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures







References
-
- Antunes LC, Finlay BB. A comparative analysis of the effect of antibiotic treatment and enteric infection on intestinal homeostasis. Gut Microbes. 2011;2:105–108. - PubMed
-
- Barnich N, Boudeau J, Claret L, Darfeuille-Michaud A. Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn’s disease. Mol Microbiol. 2003;48:781–794. - PubMed
-
- Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, Hogardt M, Pfeffer K, Russmann H, Hardt WD. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun. 2003;71:2839–2858. - PMC - PubMed
-
- Carvalho FA, Barnich N, Sauvanet P, Darcha C, Gelot A, Darfeuille-Michaud A. Crohn’s disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm Bowel Dis. 2008;14:1051–1060. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK061417/DK/NIDDK NIH HHS/United States
- T32 GM008759/GM/NIGMS NIH HHS/United States
- DK061417/DK/NIDDK NIH HHS/United States
- P30 DK034987/DK/NIDDK NIH HHS/United States
- P40 RR018603/RR/NCRR NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- P40RR018603/RR/NCRR NIH HHS/United States
- T32 GM142607/GM/NIGMS NIH HHS/United States
- DK083890/DK/NIDDK NIH HHS/United States
- R01 DK083890/DK/NIDDK NIH HHS/United States
- DP2 OD007444/OD/NIH HHS/United States
- P30 DK 34987/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases